Gilead Sciences, Inc.
GILD
$113.97
-$0.46-0.40%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 480.00M | 126.00M | 1.05B | 485.00M | 5.67B |
| Total Depreciation and Amortization | 2.77B | 2.76B | 2.76B | 2.74B | 2.69B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.46B | 9.04B | 7.76B | 7.47B | 1.95B |
| Change in Net Operating Assets | -880.00M | -1.91B | -4.10B | -2.22B | -2.30B |
| Cash from Operations | 10.83B | 10.02B | 7.47B | 8.48B | 8.01B |
| Capital Expenditure | -523.00M | -591.00M | -572.00M | -581.00M | -585.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -4.84B | -5.04B | -4.55B | -4.64B | -1.15B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.91B | 1.68B | 1.66B | 1.58B | -528.00M |
| Cash from Investing | -3.45B | -3.95B | -3.47B | -3.65B | -2.27B |
| Total Debt Issued | 3.46B | 1.00M | 1.98B | 1.98B | 1.98B |
| Total Debt Repaid | -1.97B | -1.96B | -4.10B | -2.25B | -2.25B |
| Issuance of Common Stock | 422.00M | 275.00M | 260.00M | 281.00M | 232.00M |
| Repurchase of Common Stock | -1.15B | -950.00M | -950.00M | -1.00B | -1.00B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.92B | -3.89B | -3.86B | -3.83B | -3.81B |
| Other Financing Activities | -281.00M | -267.00M | -263.00M | -261.00M | -278.00M |
| Cash from Financing | -3.43B | -6.79B | -6.93B | -5.08B | -5.13B |
| Foreign Exchange rate Adjustments | -40.00M | 52.00M | 2.00M | 26.00M | 57.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 1.00M | 0.00 |
| Net Change in Cash | 3.91B | -669.00M | -2.93B | -218.00M | 673.00M |
